Sangamo Therapeutics

$6.33

+$0.52 (+8.93%) Today

-$0.01 (-0.16%) As of 11:59 PM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell SGMO and other ETFs, options, and stocks.

About SGMO

Sangamo Therapeutics, Inc. is a clinical stage biotechnology company, which engages in the research and development of zinc finger proteins. It focuses on three therapeutic areas: inherited metabolic diseases, central nervous system, and diseases and immunology, which comprises inflammatory and autoimmune diseases.

CEO

Alexander D. Macrae

CEOAlexander D. Macrae

Employees

431

Employees431

Headquarters

Brisbane, California

HeadquartersBrisbane, California

Founded

1995

Founded1995

Employees

431

Employees431

SGMO Key Statistics

Market cap

930.00M

Market cap930.00M

Price-Earnings ratio

—

Price-Earnings ratio—

Dividend yield

—

Dividend yield—

Average volume

1.75M

Average volume1.75M

High today

$6.39

High today$6.39

Low today

$5.77

Low today$5.77

Open price

$5.77

Open price$5.77

Volume

1.47M

Volume1.47M

52 Week high

$11.49

52 Week high$11.49

52 Week low

$3.12

52 Week low$3.12

Analyst ratings

73%

of 11 ratings

Buy

72.7%

Hold

27.3%

Sell

SGMO Earnings

-$0.35

-$0.30

-$0.26

-$0.21

Q4 FY20

Q1 FY21

Q2 FY21

Q3 FY21

Q4 FY21

Q1 FY22

Q2 FY22

Estimated

-$0.35 per share

Estimated-$0.35 per share

Actual

-$0.29 per share

Actual-$0.29 per share

Replay Earnings Call